[Story ID: 3525] The Licensing Executives Society is holding its Annual Meeting in Chicago at the Chicago Sheraton Hotel & Towers September 26-29. Themed ‘
[Story ID: 3503] The Patent Buddy’s blog is looking for nominations for America’s Top Patent Prosecutors. Do you have what it takes? Who is a Top Prosecutor? A Top Patent Prosecutor is any patent attorney who has achieved a reputation among their peers for high quality work product and counseling skills in patent preparation and [...]
[Story ID: 3449] BioNetwork West 2010 The 8th Annual Pharmaceutical-Biotech Partnering Conference There are a lot of pharmaceutical and biotechnology investment conferences and Pharma-Biotech networking events in the market. BioNetwork is offering a conference that offers you the chance to spend quality time with the right people. With its intimate setting and extensive networking opportunities, [...]
[Story ID: 3397] In a nonprecidential opionion, the U.S. Court of Appeals for the Federal Circuit dismissed an appeal by Biopolymer Engineering (Biothera) as moot after it appealed a District Court order granting summary judgment of noninfringement by Immunocorp and Biotec Pharmacon ASA (Biotec). Biopolymer Engineering and MIT v. Immunocorp and Biotec Pharmacon ASA (2010-1096). [...]
[Story ID: 3382] Caraco Pharmaceutical Labs and Sun Pharmaceutical Ind. tried to get a rehearing en banc regarding the counterclaim provision of the Hatch-Waxman Act (HWA). Novo Nordisk A/S v. Caraco Pharmaceutical Labs and Sun Pharmaceutical Ind., US Court of Appeals for the Federal Circuit (2010-1001). The petition for panel rehearing and for rehearing en [...]
[Story ID: 3369] Eli Lilly lost an appeal from a final judgment of the U.S. District Court for the Eastern District of Michigan, finding claims 2, 6, and 7 of U.S. Patent No. 5,464,826 invalid for obviousness-type double patenting over its earlier U.S. Patent No. 4,808,614. See, Sun Pharmaceutical Industries v. Eli Lilly and Co., [...]
[Story ID: 3362] BioOhio Annual Conference “Innovation Road Show” This year BioOhio has decided to take its annual conference networking and learning experience around the state. At each 1-day event, the focus will be on innovation… defining it, discussing it, debating it, and understanding how essential it is from R&D through commercialization to market. For [...]
[Story ID: 3249] Hot on the heels of the Bilski decision in the US, the Australian Patent Office has now refined the Australian test for the patentability of business methods. The patent application in question relates to a ‘
[Story ID: 3183] Lilly sued Novopharm for infringement under Canadian Patent No. 2,041,113, a selection patent for the compound olanzapine (sold under the brand name Zyprexa), owned by Lilly. Olanzapine is used to treat schizophrenia. Novopharm argued that the ’113 Patent is invalid. A Federal Court judge (the trial judge) agreed with Novopharm and [...]
[Story ID: 3140] On the final day of the term, the U.S. Supreme Court released its long-anticipated decision in Bilski v. Kappos. Experts discuss the implications of the decision, and give keen insight into the case. To listen, please right click on the audio file you wish to hear and then select “Save Link As…” [...]